Experimental Tardive Dyskinesia Drug Hits Mark in Phase 3Experimental Tardive Dyskinesia Drug Hits Mark in Phase 3
Neurocrine Biosciences' drug NBI-98854 eases symptoms of tardive dyskinesia in a phase 3 study. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - October 10, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news
Big Pharma's Defeat Devices
"The worse the data on the elderly got, and the worse the potential for the FDA reaction to it got, the more J&J seemed to intensify its sales effort." So writes investigative journalist Steven Brill in his chilling, meticulously researched "docuserial" America's Most Admired Lawbreaker, concerning Johnson & Johnson's efforts to market the antipsychotic Risperdal off-label -- that is, without authorization -- to seniors with dementia and children diagnosed with pediatric bipolar disorder. The series ended its fifteen-day run on The Huffington Post last week. It follows the spring publication of Brill's compelling, widely ...
Source: Healthy Living - The Huffington Post - October 5, 2015 Category: Consumer Health News Source Type: news
Big Pharma's Defeat Devices
"The worse the data on the elderly got, and the worse the potential for the FDA reaction to it got, the more J&J seemed to intensify its sales effort." So writes investigative journalist Steven Brill in his chilling, meticulously researched "docuserial" America's Most Admired Lawbreaker, concerning Johnson & Johnson's efforts to market the antipsychotic Risperdal off-label -- that is, without authorization -- to seniors with dementia and children diagnosed with pediatric bipolar disorder. The series ended its fifteen-day run on The Huffington Post last week. It follows the spring publication of Brill's compelling, widely ...
Source: Science - The Huffington Post - October 5, 2015 Category: Science Source Type: news
Major complication of Parkinson's therapy explained
Researchers have discovered why long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia, a side effect that... (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - September 11, 2015 Category: Neurology Tags: Parkinson's Disease Source Type: news
Genetics Home Reference: ADCY5-related dyskinesia
http://ghr.nlm.nih.gov/condition/adcy5-related-dyskinesia (Source: NLM General Announcements)
Source: NLM General Announcements - July 21, 2015 Category: Databases & Libraries Source Type: news
Medical News Today: Parkinson's disease may be treatable with antimalaria drugs
Breakthrough study shows existing malaria drugs directly activate the brain receptor Nurr1 and significantly reduce Parkinson's behavior in rats without inducing dyskinesia. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 17, 2015 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news
Parkinson's disease may be treatable with antimalaria drugs
Breakthrough study shows existing malaria drugs directly activate the brain receptor Nurr1 and significantly reduce Parkinson's behavior in rats without inducing dyskinesia. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - July 17, 2015 Category: Neurology Tags: Parkinson's Disease Source Type: news
New chances for pharmacotherapy of primary ciliary dyskinesia patients
(International Institute of Molecular and Cell Biology) Primary ciliary dyskinesia is a rare, genetic respiratory tract disorder leading to progressive pulmonary dysfunction. It exhibits many problems typical for orphan diseases: delayed diagnosis, limited evidence-based knowledge etc. The European Union is funding BESTCILIA (Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia) to introduce uniform guidelines for PCD treatment and diagnosis across Europe. The latest notable accomplishment of the consortium is the initiation of the first randomized controlled trial in this disease. (Source: EurekAlert...
Source: EurekAlert! - Medicine and Health - March 23, 2015 Category: Global & Universal Source Type: news
Tardive Dyskinesia - Are Meds Affecting Your...
Tardive dyskinesia is a movement disorder that is characterized by uncontrolled facial movements such as protruding tongue, chewing or sucking motions. More... (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - February 17, 2015 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news
New therapeutic principle for Parkinsonian dyskinesia shows clinical effect
Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson's disease. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - February 11, 2015 Category: Neurology Tags: Parkinson's Disease Source Type: news
New therapeutic principle for Parkinsonian dyskinesia shows clinical effect
Involuntary dyskinetic movements induced by treatment with levodopa are a common problem for people with Parkinson's disease. Now, however, researchers seem to be close to a novel therapy to this distressing side effect. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 11, 2015 Category: Science Source Type: news
First meeting of young researchers in PCD
(International Institute of Molecular and Cell Biology) Primary ciliary dyskinesia is a rare respiratory tract disorder causing progressive lung dysfunction. The EU-funded BESTCILIA strives to create uniform guidelines for PCD diagnosis and treatment across Europe. Currently, many countries are creating PCD research groups and for the first time, young researchers working towards these goals will have a chance to present and discuss their research at the upcoming Young Researchers' Meeting in PCD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2015 Category: Global & Universal Source Type: news
Cholecystectomy for Biliary Dyskinesia in GastroparesisCholecystectomy for Biliary Dyskinesia in Gastroparesis
Is surgery being overused in cases of biliary dyskinesia, especially where the diagnosis is unclear? Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 30, 2014 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
New Article-Primary Ciliary Dyskinesia
Primary ciliary dyskinesia, or PCD, is a rare disease that affects tiny, hair-like structures that line the airways. These structures are called cilia. (Source: National Heart, Lung, and Blood Institute Health Topics)
Source: National Heart, Lung, and Blood Institute Health Topics - October 27, 2014 Category: Consumer Health News Source Type: news
Compound Formula Rehmannia alleviates dyskinesia in Parkinson's disease
(Neural Regeneration Research) Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news
